The company, which recently surpassed €800 million in annual recurring revenue with 53% year-over-year growth, plans to use the investment to deepen its presence in France, Belgium, Spain, and Canada. Beyond geographic expansion, the funds are earmarked for aggressive acquisitions and the integration of advanced artificial intelligence into its platform. By combining insurance, health coverage, and care navigation, Alan aims to replace the traditional "wait-and-treat" cycle with a system that identifies health risks before they escalate.
Alan secures €480 million to scale prevention-first healthcare
Paris-based health insurer Alan has secured a €480 million Series G funding round, pushing the company’s valuation to €5.5 billion. Led by Dutch technology investor Prosus, the capital injection aims to shift global healthcare standards from reactive treatment toward proactive, AI-driven prevention models for its 1.1 million members.
Jean-Charles Samuelian-Werve, CEO and co-founder, stated that the partnership with Prosus provides the necessary expertise to scale their model internationally. For investors, the appeal lies in Alan’s ability to create a self-reinforcing loop between insurance and care delivery. The company, which is already profitable in its home market of France, currently serves over 37,000 businesses and expects to leverage this latest financial milestone to establish prevention insurance as a global industry standard.
Comments (0)
No comments yet. Be the first!